Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH

Cancer Genetics and Cytogenetics

Volumn 150, Issue 1, 2004, Pages 27-32

  Weng, Wen Hui ^a   Wejde, Johan ^a   Åhlén, Jan ^a   Pang, See Tong ^a   Lui, Weng Onn ^a   Larsson, Catharina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL CANCER; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMOSOME ANALYSIS; CHROMOSOME MARKER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT FIBROUS HISTIOCYTOMA; ONCOGENE; PRIORITY JOURNAL; SPECTRAL KARYOTYPING;

CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 8; GENETIC MARKERS; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SARCOMA; SPECTRAL KARYOTYPING;

EID: 1642307140     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.08.009     Document Type: Article

References (31)

1. Enzinger F., Weiss S. Enzinger Weiss's soft tissue tumors. 2001;Mosby, St. Louis.
2. Antonescu C., Ladanyi M. World Health Organization classification of tumours: pathology and genetics of tumours of soft tissue and bone. 2002;IARC Press, Lyon.
3. Miller G.G., Yanchar N.L., Magee J.F., Blair G.K. Tumor karyotype differentiates lipoblastoma from liposarcoma. J Pediatr Surg. 32:1997;1771-1772.
4. Fletcher C.D. Soft tissue tumours: the impact of cytogenetics and molecular genetics. Verh Dtsch Ges Pathol. 81:1997;318-326.
5. Dei Tos A.P., Dal Cin P. The role of cytogenetics in the classification of soft tissue tumours. Virchows Arch. 431:1997;83-94.
6. Pinkel D., Segraves R., Sudar D., Clark S., Poole I., Kowbel D., Collins C., Kuo W.L., Chen C., Zhai Y., Dairkee S.H., Ljung B.M., Gray J.W., Albertson D.G. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet. 20:1998;207-211.
7. Fletcher C.D., Gustafson P., Rydholm A., Willen H., Akerman M. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol. 19:2001;3045-3050.
8. Dal Cin P., Kools P., Sciot R., De Wever I., Van Damme B., Van de Ven W., Van den Berghe H. Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet. 68:1993;85-90.
9. Rabbitts T.H., Forster A., Larson R., Nathan P. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet. 4:1993;175-180.
10. Meloni-Ehrig A.M., Chen Z., Guan X.Y., Notohamiprodjo M., Shepard R.R., Spanier S.S., Trent J.M., Sandberg A.A. Identification of a ring chromosome in a myxoid malignant fibrous histiocytoma with chromosome microdissection and fluorescence in situ hybridization. Cancer Genet Cytogenet. 109:1999;81-85.
11. Mandahl N., Heim S., Arheden K., Rydholm A., Willen H., Mitelman F. Rings, dicentrics, and telomeric association in histiocytomas. Cancer Genet Cytogenet. 30:1988;23-33.
12. Sakabe T., Shinomiya T., Mori T., Ariyama Y., Fukuda Y., Fujiwara T., Nakamura Y., Inazawa J. Identification of a novel gene, MASL1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization. Cancer Res. 59:1999;511-515.
13. Mitelman F. ISCN. An international system for human cytogenetic nomenclature. 1995;S. Karger, Basel.
14. Weng W.H., Åhlén J., Lui W.O., Brosjö O., Pang S.T., Rosen A.V., Auer G., Larsson O., Larsson C. Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease free survival and a low risk of developping distant metastasis. Br J Cancer. 89:2003;720-726.
15. Guo X., Lui W.O., Qian C.N., Chen J.D., Gray S.G., Rhodes D., Haab B., Stanbridge E., Wang H., Hong M.H., Min H.Q., Larsson C., Teh B.T. Identifying cancer-related genes in nasopharyngeal carcinoma cell lines using DNA and mRNA expression profiling analyses. Int J Oncol. 21:2002;1197-1204.
16. Gyapay G., Schmitt K., Fizames C., Jones H., Vega-Czarny N., Spillett D., Muselet D., Prud'homme J.F., Dib C., Auffray C., Morissette J., Weissenbach J., Goodfellow P.N. A radiation hybrid map of the human genome. Hum Mol Genet. 5:1996;339-346.
17. Sandberg A.A. Cytogenetics and molecular genetics of bone and soft-tissue tumors. Am J Med Genet. 115:2002;189-193.
18. Mertens F., Fletcher C.D., Dal Cin P., De Wever I., Mandahl N., Mitelman F., Rosai J., Rydholm A., Sciot R., Tallini G., Van den Berghe H., Vanni R., Willen H. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and morphology. Genes Chromosomes Cancer. 22:1998;16-25.
19. Szymanska J., Tarkkanen M., Wiklund T., Virolainen M., Blomqvist C., Asko-Seljavaara S., Tukiainen E., Elomaa I., Knuutila S. A cytogenetic study of malignant fibrous histiocytoma. Cancer Genet Cytogenet. 85:1995;91-96.
20. Gisselsson D., Pettersson L., Hoglund M., Heidenblad M., Gorunova L., Wiegant J., Mertens F., Dal Cin P., Mitelman F., Mandahl N. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci USA. 97:2000;5357-5362.
21. Gisselsson D., Hoglund M., Mertens F., Johansson B., Dal Cin P., Van den Berghe H., Earnshaw W.C., Mitelman F., Mandahl N. The structure and dynamics of ring chromosomes in human neoplastic and non-neoplastic cells. Hum Genet. 104:1999;315-325.
22. Chibon F., Mariani O., Derre J., Malinge S., Coindre J.M., Guillou L., Lagace R., Aurias A. A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas. Cancer Genet Cytogenet. 139:2002;24-29.
23. Mezzelani A., Sozzi G., Nessling M., Riva C., Della Torre G., Testi M.A., Azzarelli A., Pierotti M.A., Lichter P., Pilotti S. Low grade fibromyxoid sarcoma. A further low-grade soft tissue malignancy characterized by a ring chromosome. Cancer Genet Cytogenet. 122:2000;144-148.
24. Pedeutour F., Forus A., Coindre J.M., Berner J.M., Nicolo G., Michiels J.F., Terrier P., Ranchere-Vince D., Collin F., Myklebost O., Turc-Carel C. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer. 24:1999;30-41.
25. Orndal C., Mandahl N., Rydholm A., Willen H., Brosjo O., Heim S., Mitelman F. Supernumerary ring chromosomes in five bone and soft tissue tumors of low or borderline malignancy. Cancer Genet Cytogenet. 60:1992;170-175.
26. Barrios C., Castresana J.S., Ruiz J., Kreicbergs A. Amplification of the c-myc proto-oncogene in soft tissue sarcomas. Oncology. 51:1994;13-17.
27. Martinerie C., Viegas-Pequignot E., Guenard I., Dutrillaux B., Nguyen V.C., Bernheim A., Perbal B. Physical mapping of human loci homologous to the chicken nov proto-oncogene. Oncogene. 7:1992;2529-2534.
28. Astolfi A., De Giovanni C., Landuzzi L., Nicoletti G., Ricci C., Croci S., Scopece L., Nanni P., Lollini P.L. Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells. Gene. 274:2001;139-149.
29. Pedeutour F., Suijkerbuijk R.F., Forus A., Van Gaal J., Van de Klundert W., Coindre J.M., Nicolo G., Collin F., Van Haelst U., Huffermann K. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosomes Cancer. 10:1994;85-94.
30. Forus A., Bjerkehagen B., Sirvent N., Meza-Zepeda L.A., Coindre J.M., Berner J.M., Myklebost O., Pedeutour F. A well-differentiated liposarcoma with a new type of chromosome 12-derived markers. Cancer Genet Cytogenet. 131:2001;13-18.
31. Forus A., Florenes V.A., Maelandsmo G.M., Meltzer P.S., Fodstad O., Myklebost O. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2. Cell Growth Differ. 4:1993;1065-1070.